Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder, a combination therapy digital inhaler with built-in sensors that connects to a companion mobile application to provide information on inhaler use to people with asthma.
The Asthma and Allergy Foundation of America (AAFA) addresses concerns regarding the Final Evidence Report assessing the clinical effectiveness and value of treatments for peanut allergy released by the Institute for Clinical and Economic Review (ICER) on July 10, 2019. ICER’s report may cause concern for the allergy community that the findings will restrict access to new treatments for peanut allergy.
The U.S. Food and Drug Administration today approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied by chronic rhinosinusitis (prolonged inflammation of the sinuses and nasal cavity). This is the first treatment approved for inadequately controlled chronic rhinosinusis with nasal polyps.
Did you know you may be able to tell when an asthma episode or attack is about to start before you have trouble breathing? Knowing your early warning signs (or mild symptoms) can be helpful so you can begin asthma treatment as soon as possible.
Did you know pollen might be responsible for your food allergy? If your mouth or throat itch when you eat certain fruit or vegetables, you could have oral allergy syndrome (OAS). And you would have a pollen allergy to thank for that.
On June 11, 2019, in Oakland, California, the Institute for Clinical and Economic Review (ICER) and its California Technology Assessment Forum (CTAF) met to assess the clinical effectiveness and value of treatments for peanut allergy. The review examined two new technologies to induce immune tolerance — Viaskin® Peanut (DBV Technologies) and AR101 (Aimmune Therapeutics) — as well as non-commercialized oral immunotherapy (OIT).
Out of the 25 million people who have asthma, about 60% of them have allergic asthma. If you have allergic asthma, this means allergens trigger asthma symptoms. Immunotherapy may help allergic asthma symptoms.
AAFA applauds the warning the U.S. Department of Transportation (USDOT) issued to American Airlines in response to American Airline’s denial of the right to pre-board a family of a child with food allergies. However, AAFA calls on the USDOT and Congress to take even stronger actions to protect the rights of airline passengers with allergies and all disabilities.
Four years ago, Deborah Bartlett of New Haven, Connecticut (overall #11 on Asthma Capitals), was diagnosed with severe persistent asthma. Combined with her pollen and mold allergies, as well as COPD, breathing can be a real challenge.
To understand asthma , a chronic disease that causes your airways to become inflamed, it helps to first know how your airways work. Watch on YouTube How Do Normal Airways Work? When we breathe in, air moves through our airways – from our nose or mouth, down a large hollow tube in the front of the neck called a windpipe or trachea – and into our lungs. The trachea divides into two tubes called bronchial [bron-KEE-uhl] tubes in the lungs. They look like upside-down trees. As the bronchial...
Jessica Barber Brown and her son Isaac, age 11, live about 45 minutes outside of Louisville, Kentucky (overall #7 on Asthma Capitals), in Lawrenceburg. Both Jessica and Isaac have asthma and allergies.
Asthma is the third-leading cause of hospital stays in children. Hospitalizations among children are higher during Asthma Peak Week in September when children return to school and are exposed to more asthma triggers, allergens and respiratory infections.
We urge Congress to support the School-Based Allergies and Asthma Management Program Act (H.R. 2468) to put important protections in place for children with asthma and allergies.
The Asthma and Allergy Foundation of America (AAFA) conducted the My Life With Asthma survey to highlight the challenges people with asthma, especially severe asthma, face. We found that people with asthma have concerns beyond their physical health. Many deal with fear and worry.
Asthma and allergies affect more than 60 million Americans. Allergic disease, which includes asthma, is the fifth leading chronic disease in the U.S. They can impact you socially, emotionally and financially. But asthma and allergies don't have to define you. But working with your doctor and following your treatment plan, you can thrive and do many of the things you enjoy doing.